We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · October 01, 2022

Evaluating Primary Endpoints for COVID-19 Therapeutic Trials to Assess Recovery

American Journal of Respiratory and Critical Care Medicine

 

Additional Info

American Journal of Respiratory and Critical Care Medicine
Evaluating Primary Endpoints for COVID-19 Therapeutic Trials to Assess Recovery
Am J Respir Crit Care Med 2022 Sep 15;206(6)730-739, DJ Douin, L Siegel, G Grandits, A Phillips, NR Aggarwal, J Baker, SM Brown, CC Chang, AL Goodman, B Grund, ES Higgs, CL Hough, DD Murray, R Paredes, M Parmar, S Pett, MN Polizzotto, U Sandkovsky, WH Self, BE Young, AG Babiker, VJ Davey, V Kan, AC Gelijns, G Matthews, BT Thompson, HC Lane, JD Neaton, JD Lundgren, AA Ginde

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading